152252 people have viewed this drug in the last 60 days
Updated 2025-05-07
| Last Update | 2022-08-31 |
| Register Year | 2021 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | RAVULIZUMAB |
| Trade Name | Ultomiris 300 mg/30 mL |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L04AA |
| Atc Code2 | |
| Size | 30 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $25560.5 |
| Shelf Life | 30 Months |
| Marketing Company | Alexion Pharmaceuticals Inc |
| Marketing Country | United States |
| Manufacture Name | Alexion Pharma International Operations Unlimited Company |
| Manufacture Country | Ireland |
| Secondry package manufacture | |
| Main Agent | Salehiya Trading Co. |
| Secosnd Agent | |
| Third Agent | |
| Visits | 152252 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Ultomiris 300 mg/30 mL | $25560.5 | 152252 visits | 2022-08-31 |